Inspired by the stunning IMAX experience of Oppenheimer, Dwayne Johnson was tempted to release his upcoming Christmas movie, ...

The Rock can always put a wildly positive spin on any of his movies, but his latest promotional clip takes the cake: he’s ...

COUNTY NEWS RELEASE The Los Alamos Public Library will host Dr. Porter Swentzell of Santa Clara Pueblo on Saturday, November 16, 2024, from 3:00 to 4:00 p.m. at Mesa Public Library. Dr. Swentzell ...

Oppenheimer analyst Kristen Owen maintained a Buy rating on Bioceres Crop Solutions (BIOX – Research Report) today and set a price target of $13.00. The company’s shares closed yesterday at $6.66.

Christopher Nolan's next film after Oppenheimer was revealed last month, and while we have no details on what it is about, we ...

Oppenheimer analysts initiated coverage on five key storage and infrastructure stocks on Wednesday, offering insights into ...

Zendaya's upcoming role in Christopher Nolan's new film may be a brief one, while Tom Holland takes center stage in a ...

Pure Storage edged about 4.5% higher during Wednesday trading after Oppenheimer initiated coverage on the stock with an ...

If Marco Rubio becomes secretary of state, he may brand Venezuela’s Tren de Aragua gang as a “terrorist” group. Here’s why it ...

Oppenheimer began coverage of Nutanix (NASDAQ:NTNX) with an Outperform rating and an $80 price target. Analyst Param Singh noted that their bullish stance is based on their view that Nutanix — is a ...

Backers of some sure-fire hits are hoping for the former. Denis Villeneuve’s “Dune: Part Two” has already taken in $714.4 ...

In a report released today, Matthew Biegler from Oppenheimer maintained a Hold rating on Fate Therapeutics (FATE – Research Report). The company’s shares closed yesterday at $2.38. According to ...